When childhood atopic dermatitis persists into adulthood, the large reduction in quality of life suggests that the price of ...

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.

Discover research presented at EADV 2024 highlighting the significant impact of atopic dermatitis on psychological and social ...

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

Treatment for a rash on or inside the buttocks may include a combination of creams, self-care, or antivirals. Find a list of ...

Union Therapeutics is looking to advance its PDE4 inhibitor, orismilast, into a Phase III clinical trial for atopic ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...

Treatment for a rash on or inside the buttocks may include a combination of creams, self-care, or antivirals. Find a list of options here.

ConfiDENT Dental is proud to announce that it has been voted the Best Oral Surgery and the First Runner-Up in Dentistry in North Atlanta for 2024. The team at ConfiDENT Dental extends their heartfelt ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...

SCIB], pioneering prevention and prediction in dermatology disorders is pleased to announce the completion of a milestone sale of Nevisense, a leading skin barrier research device, to the National ...